Barriers and facilitators of optimal HIV care among prisoners in South Ethiopia: an exploratory study

Author:

Fuge Terefe Gone1,Tsourtos George2,Miller Emma R3

Affiliation:

1. Wachemo University

2. Flinders University

3. The University of Adelaide

Abstract

Abstract Background Optimal care is crucial for ensuring both therapeutic and preventative benefits of antiretroviral therapy (ART). Sub-optimal care use is common in prisoners and little information is available about its predisposing circumstances in resource-limited settings. We explored barriers to and facilitators of HIV care use amongst inmates living with HIV (ILWH) in South Ethiopia with the aim of suggesting contextually tailored solutions that help ensure universal access to care. Methods We conducted qualitative in-depth interviewing with eleven ILWH and eleven service providers. Audio recorded interview data were transcribed verbatim in Amharic language, translated into English and coded based on emerging themes. A phenomenological approach was employed to abstract meaning attributed to the prisoners’ lived experiences in relation to HIV care use and service providers’ experiential account regarding care provision. Findings Several themes emerged as barriers to HIV care use amongst ILWH in South Ethiopia including: limited access to standard care, insufficient health staff support, uncooperative security system, loss of patient privacy, a lack of status disclosure due to social stigma, and food supply insufficiency. In addition to a unique opportunity offered by an imprisonment for some ILWH to refrain from health damaging behaviours, the presence of social support in the prison system facilitated care use. Conclusions This study identified important structural, social and personal contexts that can both hinder and enhance HIV care use amongst ILWH in South Ethiopia. Given the disproportionate burden of HIV in prisoners and the potential of transmission to others during and after incarceration, development of contextually responsive strategies is required to address the barriers and to also strengthen the enablers.

Publisher

Research Square Platform LLC

Reference58 articles.

1. World Health Organization (WHO). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva, Switzerland: WHO; 2013.

2. World Health Organization (WHO). Adherence to long-term therapies: evidence for action. Human immunodeficiency virus and acquired immunodeficiency syndrome. Geneva, Switzerland: WHO; 2003.

3. World Health Organization (WHO). Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations: 2016 update. Geneva, Switzerland: WHO; 2016.

4. Determinants of virological failure and antiretroviral drug resistance in Mozambique;Ruperez M;J Antimicrob Chemother,2015

5. Outcomes of patients lost to follow-up in African antiretroviral therapy programs: individual patient data meta-analysis;Chammartin F;Clin Infect Dis,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3